Carregant...

Ageing is a risk factor in imatinib mesylate cardiotoxicity

AIMS: Chemotherapy-induced heart failure is increasingly recognized as a major clinical challenge. Cardiotoxicity of imatinib mesylate, a highly selective and effective anticancer drug belonging to the new class of tyrosine kinase inhibitors, is being reported in patients, some progressing to conges...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Eur J Heart Fail
Autors principals: Maharsy, Wael, Aries, Anne, Mansour, Omar, Komati, Hiba, Nemer, Mona
Format: Artigo
Idioma:Inglês
Publicat: John Wiley & Sons, Ltd 2014
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4238824/
https://ncbi.nlm.nih.gov/pubmed/24504921
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ejhf.58
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!